Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

16260 Ventura Blvd., Suite 140
Encino, CA 91436
Phone: 818-528-7776

August 4, 2022 by Alan Khadavi

Lentil Allergy, a common allergen on the rise

lentil allergy

Lentil allergy, although not very common in the United States, is an important allergen worldwide. Legumes in general are an important cause of food allergies worldwide. A recent study looked at the characteristics of food food allergy in Turkish children, this study was published in Pediatric Allergy and Immunology. Lentils are in the family of legumes, […]

Filed Under: Blog, Food allergy

July 24, 2022 by Alan Khadavi

Viaskin Peanut Patch Safety Results

viaskin peanut patch

The Viaskin Peanut Patch is still being studied in clinical trials. Current treatment options for peanut allergy are limited. Peanut allergy is common with increasing prevalence reported. Peanut allergy only resolves in approximately 20% of children, otherwise it remains lifelong. Currently the only FDA approved treatment for peanut allergy is Palforzia. Palforzia (formerly AR101) and […]

Filed Under: Blog, Food allergy

July 15, 2022 by Alan Khadavi

Flaxseed Allergy, an emerging allergen

flaxseed allergy

Flaxseed allergy is a rare though emerging allergen.  Flaxseeds are consumed and added to cereals and cooked foods. It is also used for their laxative effect and it also has a high content of omega 3 fatty acids. Allergy to flaxseed has been rising partly probably due to its increased consumption over the last few […]

Filed Under: Anaphylaxis, Blog, Food allergy

July 5, 2022 by Alan Khadavi

Itepekimab (Anti IL-33) & Brodalumab (Anti IL-25) for Asthma

Itepekimab and Brodalumab

Itepekimab and Brodalumab are two biologic medications being studied for asthma. Current biologics including Xolair, Nucala, Fasenra and Dupixent target downstream IgE, cytokines IL-5 and IL-4/13, have shown promising effects in terms of reduced asthma exacerbation rates, oral steroids, improved breathing capacity and asthma scores. However approximately 30% of patients receiving biologics do not improve […]

Filed Under: Asthma, biologics, Blog

June 18, 2022 by Alan Khadavi

Roflumilast and Tapinarof; Emerging Therapies for Atopic Dermatitis

roflumilast tapinarof

Roflumilast and Tapinarof are 2 emerging topical therapies that have completed or have ongoing phase 3 clinical trials, with the possibility of approval in 2022. Roflumilast is a more potent PDE4 inhibitor than crisaborloe (Eucrisa) with fewer local reactions. Tapinarof, the first therapeutic arylhydocarbon modulating agent for which the only associated local effect is noninfectious […]

Filed Under: atopic dermatitis, Blog, Medications, Uncategorized

June 9, 2022 by Alan Khadavi

Avocado Allergy Comes in Many Flavors

avocado allergy

Avocado allergy is not commonly reported, but it can cause adverse reactions. The avocado (Av) is a fruit that belongs to the Lauraceae family. Hypersensitivity reactions to other fruits are commonly reported, particularly apples, stone fruits and bananas. Avocados have a creamy, nutty flavor that some people describe as almost buttery. Health benefits of avocado […]

Filed Under: Blog, Food allergy

May 24, 2022 by Alan Khadavi

Lirentelimab study for Chronic Urticaria (Hives)

lirentelimab

Lirentelimab is an anti-sialic acid-binding immunoglobulin-like lectin 8 mAb that selectively inhibits mast cells and depletes eosinophils. It is being studied for chronic urticaria that is often refractory to standard therapy. Stepwise approach to Chronic Urticaria (Chronic Hives) Chronic urticaria is a mast cell disease that causes recurrent itching, hives and angioedema for more than […]

Filed Under: biologics, Blog

May 24, 2022 by Alan Khadavi

Dupixent for EoE (Eosinophilic Esophagitis); FDA approved and New Dosing

dupixent for eoe

Dupixent for EoE (eosinophilic esophagitis) was recently approved by the FDA. This will be the first drug officially approved for EoE. Eosinophilic Esophagitis is a chronic inflammatory immune disorder of the esophagus where eosinophils (a type of white blood cell) builds up in the esophagus. This can cause symptoms of difficulty swallowing, eating or food […]

Filed Under: biologics, Blog

April 30, 2022 by Alan Khadavi

What are the best foods for Asthma?

best foods for asthma

As an asthma doctor, I am often asked what are the best foods for asthma? Before we begin, it should be noted that no foods will help relieve an asthma attack. But your daily diet plays a role in your overall health to keep you healthy and reduce symptoms of asthma. Asthma is a chronic […]

Filed Under: Asthma, Blog, Headlines

April 26, 2022 by Alan Khadavi

Best Nasal Polyps Treatment

best nasal polyps treatment

With so many options available, the best nasal polyps treatment can be hard to pick. Chronic rhinosinusitis with nasal polyps is an inflammatory disease of the upper airways characterized by polyp growth in the nasal passages. It causes severe congestion, discharge and difficulty with smell. The best treatment option is unclear. A study published in […]

Filed Under: biologics, Blog

  • 1
  • 2
  • 3
  • …
  • 39
  • Next Page »

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

August 4, 2022

Lentil Allergy, a common allergen on the rise

lentil allergy

July 24, 2022

Viaskin Peanut Patch Safety Results

viaskin peanut patch

July 15, 2022

Flaxseed Allergy, an emerging allergen

flaxseed allergy

July 5, 2022

Itepekimab (Anti IL-33) & Brodalumab (Anti IL-25) for Asthma

Itepekimab and Brodalumab

June 18, 2022

Roflumilast and Tapinarof; Emerging Therapies for Atopic Dermatitis

roflumilast tapinarof

June 9, 2022

Avocado Allergy Comes in Many Flavors

avocado allergy

May 24, 2022

Lirentelimab study for Chronic Urticaria (Hives)

lirentelimab

May 24, 2022

Dupixent for EoE (Eosinophilic Esophagitis); FDA approved and New Dosing

dupixent for eoe

April 30, 2022

What are the best foods for Asthma?

best foods for asthma

April 26, 2022

Best Nasal Polyps Treatment

best nasal polyps treatment

Read More Posts...

Follow Us…

© 2022 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page